最近研究表明，血小板生成减少可能与ITP发生有关。
Recent evidences suggest that decreased platelet production may also contribute to the development of ITP.
特发性血小板减少性紫癜(itp)是一种免疫机制参与而使血小板生成减少和破坏增多的疾病。
Idiopathic thrombocytopenic purpura is the disease with participation of immunologic mechanism with decreased thrombocytopoiesis and increased platelet destruction.
由于骨髓无法生成健康的红细胞，急性骨髓性白血病患者的正常红细胞和血小板会减少，导致病人出现贫血和血小板过低的症状。
In APL, there is a drop in the production of normal red blood cells and platelets, resulting in anemia and thrombocytopenia. The bone marrow is unable to produce healthy red blood cells.
APT102是一种十分有趣的药物，它可以减少一种叫做ADP的物质，这种物质是由肿瘤细胞释放出来的，并可以促进血小板的生成。
APT102 is an especially interesting drug because it gets rid of a compound called ADP, which tumor cells release and which stimulates platelets to clump.
目的探讨血小板生成素(TPO)在血小板减少性疾病中的诊断意义。
Objective to explore the diagnostic value of serum level of thrombopoietin (TPO) for thrombocytopenic diseases.
目的探讨血小板生成素（TPO）和巨核细胞计数对特发性血小板减少性紫癜（ITP）患儿预后的意义。
Objective To explore the prognosis of idiopathic thrombocytopenic purpura(ITP) in serum levels of thrombopoietin(TPO) and number of megakaryocyte.
目的探讨网织血小板、血小板生成素对诊断特发性血小板减少性紫癜的意义。
Objective To study the significance of reticulated platelet and thrombopoietin in the diagnosis of idiopathic thrombocytopenic purpura.
这是一种新的血小板生成剂治疗儿童免疫性血小板减少症（ITP）的首例研究成果。
This is the first publication of the results of one of the new thrombopoietic agents in the treatment of children with immune thrombocytopenia (ITP).
这是一种新的血小板生成剂治疗儿童免疫性血小板减少症（ITP）的首例研究成果。
This is the first publication of the results of one of the new thrombopoietic agents in the treatment of children with immune thrombocytopenia (ITP).
应用推荐